Counting on a vaccine is not realistic, let's look at the company without a vaccine?? I think we are in a critical phase, another lawsuit , no funding, no revenue, no NASDAQ. Which company will fund Generex at this stage with debt, S1 approval questionable and acquisitions/financing based on 2.50-3.50 pps. So far this world class management team has failed to meet expected results!! Too bad a rapid test was not available when we had a huge opportunity. Another failed product that most of us thought we had available and ready to go!! At this point I just like to know our valuation, cash in the bank and total debt.